Table 5.
Outcome | |||||
---|---|---|---|---|---|
Marker | IGF-1 CA- Z |
IGF-1 BA-Z |
IGFBP-3 CA- Z |
IGFBP-3 BA-Z |
|
ESR | *ΔR2 | 10.0 | 9.1 | 5.5 | 5.6 |
P Val** | .002 | .02 | .07 | .14 | |
CRP | ΔR2 | 17.1 | 13.7 | 3.5 | 3.6 |
P Val | .0001 | .003 | .07 | .11 | |
Albumin | ΔR2 | 6.7 | 19.5 | 0.2 | 0.0 |
P Val | .01 | .001 | .65 | .95 | |
BMI | ΔR2 | 10.7 | 3.2 | 0.2 | 0.2 |
P Val | .007 | .16 | .67 | .70 | |
Sex Hormone Z |
ΔR2 | 13.1 | 11.3 | 11.3 | 0.4 |
P Val | .002 | .007 | .004 | .62 |
ΔR2 is the increase in R2 when the marker is added to a baseline model for the outcome, including sex and Tanner stage as predictors in the baseline model.
Likelihood ratio test